- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Dry Age Related Macular Degeneration in Germany
Total 375 results
-
Apheresis Research InstituteCompletedDry Age Related Macular DegenerationGermany
-
LumiThera, Inc.CompletedDry Age-related Macular DegenerationUnited Kingdom, Spain, France, Germany, Italy
-
University of JenaCompleted
-
University of LuebeckCompletedAge-Related Macular Degeneration | Retinal FunctionGermany
-
Johann Wolfgang Goethe University HospitalCompletedAge-Related Macular DegenerationGermany
-
BayerRegeneron PharmaceuticalsCompletedWet Age-related Macular DegenerationGermany
-
Gyroscope Therapeutics LimitedNovartis PharmaceuticalsActive, not recruitingDry Age-related Macular DegenerationUnited States, Germany, United Kingdom, Spain, Poland, Australia, France, Netherlands
-
Gyroscope Therapeutics LimitedNovartis PharmaceuticalsActive, not recruitingDry Age-related Macular DegenerationUnited States, Germany, United Kingdom, France, Spain, Australia, Poland
-
National Eye Institute (NEI)Completed
-
Johannes Gutenberg University MainzNovartisCompletedNeovascular Age-related Macular DegenerationGermany
-
Novartis PharmaceuticalsCompleted
-
University of LuebeckCompletedAge-Related Macular DegenerationGermany
-
Klinikum Chemnitz gGmbHCompletedAge Related Macular Degeneration | Epiretinal Membrane | Macular HolesGermany
-
Novartis PharmaceuticalsCompletedNeovascular Age-Related Macular DegenerationSpain, Italy, Germany, Canada, Ireland
-
Newtricious R&D BVSprim Advanced Life SciencesCompletedAge-related Macular Degeneration (AMD)United States, Germany, Netherlands, United Kingdom
-
University Hospital, BonnCompletedAge Related Macular DegenerationGermany
-
University of JenaCompletedAge Related MaculopathyGermany
-
University Hospital, BonnCompletedNonexudative Age-related Macular DegenerationGermany
-
Frank G. HolzRadboud University Medical Center; Bayer; Hoffmann-La Roche; Novartis Pharmaceuticals and other collaboratorsActive, not recruitingAge Related Macular Degeneration (AMD)Germany, Italy, Netherlands, United Kingdom, France, Portugal, Denmark
-
VisionCare, Inc.RecruitingAge-Related Macular Degeneration | AMDItaly, Ireland, Spain, Germany, United Kingdom
-
Klinikum LudwigshafenPfizerUnknownAge-related Macular DegenerationGermany
-
BayerRecruitingVisual Impairment | Neovascular Age-related Macular Degeneration (nAMD) | Diabetic Macula Edema (DME)Germany, Canada, Denmark, France, Italy, Saudi Arabia, Switzerland, Australia, Finland, Netherlands, Sweden, Norway, United Arab Emirates, Japan, United Kingdom
-
Klinikum Bremen-Mitte, gGmbHKompetenzzentrum für Klinische Studien, BremenUnknownAge-Related Neovascular Macular DegenerationGermany
-
University Hospital TuebingenCompletedStress | Age-related Macular DegenerationGermany
-
Hoffmann-La RocheRecruitingNeovascular Age-related Macular Degeneration (nAMD)Belgium, Korea, Republic of, Germany, Spain, United Kingdom, Australia, Italy, Argentina, Israel, Austria, Brazil, France, Singapore, Switzerland, Taiwan, Turkey
-
Hoffmann-La RocheRecruitingNeovascular Age-Related Macular DegenerationBelgium, United States, United Kingdom, Italy, Argentina, Spain, Israel, Australia, Austria, Brazil, Germany, Switzerland, Taiwan, France
-
University of RegensburgDr. Werner Jackstaedt FoundationUnknownAge-Related Macular Degeneration | Central Serous Chorioretinopathy | Diabetic MaculopathyGermany
-
Novartis PharmaceuticalsCompletedAge-related Macular DegenerationGermany, Switzerland
-
Bioeq GmbHCompletedAge-related Macular Degeneration (AMD)France, Italy, Poland, Russian Federation, Spain, United Kingdom, Germany, Hungary, Ukraine, Austria, Czechia, Israel
-
University Hospital MuensterUnknown
-
Novartis PharmaceuticalsCompletedNeovascular Age-related Macular DegenerationGermany, Austria, Belgium, Denmark, Switzerland, France, Netherlands, Portugal, Sweden, Norway
-
Samsung Bioepis Co., Ltd.CompletedAge-Related Macular DegenerationKorea, Republic of, United States, India, Germany, Hungary, United Kingdom, Czechia, Poland, Russian Federation
-
OccuLogixSuspendedAge-Related MaculopathyUnited States, Germany, Canada
-
Shanghai Henlius BiotechActive, not recruitingA Phase 3 Study to Compare the Efficacy and Safety of HLX04-O With Ranibizumab in Subjects With wAMDAge Related Macular DegenerationUnited States, Singapore, Spain, Germany, Slovakia, China, Hungary, Australia, Bulgaria, Poland, Latvia, Czechia, France, Italy, Serbia
-
Novartis PharmaceuticalsCompletedNeovascular Age-related Macular DegenerationGermany, Turkey, Austria, Canada, Czechia, United Kingdom, Hungary, Italy, Lithuania, Guatemala, France, Ireland, Argentina, Portugal, Spain, Sweden, Greece, Switzerland, Slovakia, Finland, Netherlands, Colombia, Mexico, Panama
-
ThromboGenicsCompletedExudative Age-Related Macular Degeneration | Focal Vitreomacular AdhesionUnited States, United Kingdom, Germany, France, Belgium, Italy
-
SandozCompletedNeovascular Age-related Macular DegenerationUnited States, Bulgaria, Czechia, Australia, Austria, France, Germany, Hungary, Israel, Japan, Latvia, Lithuania, Poland, Portugal, Slovakia, Spain
-
Opthea LimitedRecruitingNeovascular Age-related Macular DegenerationUnited States, Argentina, Australia, Brazil, Bulgaria, Canada, Colombia, Czechia, Denmark, France, Germany, Greece, Hungary, India, Israel, Italy, Korea, Republic of, Latvia, Malaysia, Poland, Spain, Thailand, Ukraine, United Kingdom
-
Opthea LimitedActive, not recruitingNeovascular Age-related Macular DegenerationUnited States, Argentina, Australia, Austria, Brazil, Bulgaria, Canada, Colombia, Croatia, Czechia, Denmark, Estonia, France, Germany, Greece, Hungary, India, Israel, Italy, Korea, Republic of, Latvia, Lithuania, Netherlands, Philippines and more
-
Hoffmann-La RocheActive, not recruitingNeovascular Age-related Macular DegenerationUnited States, Korea, Republic of, United Kingdom, Japan, Canada, Turkey, Argentina, Australia, Denmark, France, Germany, Hungary, Italy, Poland, Spain, Singapore, Austria, Brazil, Hong Kong, Israel, Portugal, Russian Federation, Ta... and more
-
Chengdu Kanghong Biotech Co., Ltd.TerminatedNeovascular Age-related Macular DegenerationUnited States, Argentina, Australia, Austria, Belgium, Canada, Chile, Colombia, Germany, Hong Kong, Lithuania, Mexico, Netherlands, New Zealand, Peru, Philippines, Poland, Portugal, Singapore, Spain, Switzerland, Taiwan
-
Genentech, Inc.RecruitingAge-Related Macular DegenerationFrance, Germany, Israel, United States, Australia, Puerto Rico, Italy
-
University Hospital, BonnCompletedAge-related Macular DegenerationGermany
-
AmgenParexelCompletedNeovascular (Wet) Age-related Macular Degeneration (AMD)Spain, United States, Czechia, Serbia, Israel, Canada, Germany, Japan, Hungary, Poland, Korea, Republic of, Estonia, Hong Kong, Italy, Latvia, Lithuania, Mexico, Slovakia
-
Ophthotech CorporationTerminatedAge-Related Macular DegenerationIsrael, United States, Germany, Denmark, France, Turkey, Hungary, Colombia, Australia, Argentina, Spain
-
Novartis PharmaceuticalsCompletedNeovascular Age-related Macular DegenerationUnited States, Czechia, Italy, Taiwan, Australia, Israel, Belgium, France, Spain, Germany, Korea, Republic of, Portugal, Sweden, Netherlands, Malaysia, Switzerland
-
AllerganCompletedAge-related Macular DegenerationUnited States, Italy, Australia, Israel, Germany, Austria, France, Switzerland
-
Ophthotech CorporationTerminatedAge-Related Macular DegenerationFrance, Israel, Italy, United States, Spain, Portugal, Germany, Austria, Canada, Czechia, Estonia, Latvia, Poland, Slovakia, Australia, Hungary, Croatia, Argentina, Finland, Brazil, Colombia, Norway
-
Novartis PharmaceuticalsActive, not recruitingDiabetic Macular Edema (DME) | Neovascular Age-related Macular Degeneration (nAMD)Germany
-
Oraya Therapeutics, Inc.CompletedEye Diseases | Age-Related Macular Degeneration | Macular Degeneration | Retinal Diseases | AMD | Wet AMD | Wet Age-Related Macular DegenerationUnited Kingdom, Czech Republic, Austria, Germany, Italy